Edition:
India

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

255.49USD
17 Nov 2017
Change (% chg)

$-0.77 (-0.30%)
Prev Close
$256.26
Open
$255.84
Day's High
$256.59
Day's Low
$254.69
Volume
36,738
Avg. Vol
35,982
52-wk High
$268.40
52-wk Low
$169.64

Select another date:

Fri, Nov 3 2017

BRIEF-Bio Rad Laboratories reports Q3 earnings per share $0.91

* Bio Rad Laboratories Inc reports third-quarter 2017 financial results

BRIEF-U.S. ITC to probe certain 10X Genomics devices after Bio-Rad complaint

* U.S. U.S. International Trade Commission says it will investigate certain microfluidic devices by 10x Genomics Inc after complaint by Bio-rad Laboratories Inc and Lawrence Livermore National Security LLC. Source text for Eikon: Further company coverage: (Reporting By Susan Heavey)

BRIEF-Bio-Rad reports Q2 earnings per share $0.17

* Q2 earnings per share view $0.56 -- Thomson Reuters I/B/E/S

BRIEF-Virbac signs a research agreement with Bio-Gene

* VIRBAC SA - VIRBAC SIGNS A RESEARCH AGREEMENT WITH BIO-GENE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Bio Rad Laboratories receives FDA clearance for Bioplex 2200 syphilis total & RPR assay​

* Bio Rad Laboratories Inc - ‍has received U.S. Food and Drug Administration clearance for its Bioplex 2200 syphilis total & RPR assay​ Source text for Eikon: Further company coverage:

BRIEF-Bio-Rad introduces enhanced options with its IH-COM data management software

* Bio-Rad introduces enhanced options with its IH-COM data management software for managing patient results with the IH-1000 system Source text for Eikon: Further company coverage:

Select another date: